Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

What B cell memories are made of.

Tomayko MM, Allman D.

Curr Opin Immunol. 2019 Apr;57:58-64. doi: 10.1016/j.coi.2019.01.003. Epub 2019 Mar 9. Review.

PMID:
30861463
2.

Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Coleman E, Ko C, Dai F, Tomayko MM, Kluger H, Leventhal JS.

J Am Acad Dermatol. 2019 Apr;80(4):990-997. doi: 10.1016/j.jaad.2018.10.062. Epub 2018 Nov 3.

PMID:
30399387
3.

Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.

Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS.

J Am Acad Dermatol. 2018 Dec;79(6):1081-1088. doi: 10.1016/j.jaad.2018.07.008. Epub 2018 Jul 17.

PMID:
30025829
4.

Image Gallery: Juvenile autoimmune pemphigus presenting with diffuse gingival hypertrophy and antibodies against desmocollin 3.

Leventhal JS, Haberland CM, Cowper SE, Tomayko MM.

Br J Dermatol. 2017 Nov;177(5):e226. doi: 10.1111/bjd.15954. Review. No abstract available.

PMID:
29192983
5.

Bullous systemic lupus erythematosus in a 6-year-old boy.

Li AW, Weed JG, Stamey CR, Subtil A, Tomayko MM, Antaya RJ.

Pediatr Dermatol. 2017 Nov;34(6):e313-e316. doi: 10.1111/pde.13258. Epub 2017 Aug 29.

PMID:
28851077
6.

Development of bullous pemphigoid during nivolumab therapy.

Damsky W, Kole L, Tomayko MM.

JAAD Case Rep. 2016 Dec 3;2(6):442-444. eCollection 2016 Nov. No abstract available.

7.

CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype.

Zuccarino-Catania GV, Sadanand S, Weisel FJ, Tomayko MM, Meng H, Kleinstein SH, Good-Jacobson KL, Shlomchik MJ.

Nat Immunol. 2014 Jul;15(7):631-7. doi: 10.1038/ni.2914. Epub 2014 Jun 1.

8.

CD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence.

Conter LJ, Song E, Shlomchik MJ, Tomayko MM.

PLoS One. 2014 Mar 24;9(3):e92009. doi: 10.1371/journal.pone.0092009. eCollection 2014.

9.

Multiple transcription factor binding sites predict AID targeting in non-Ig genes.

Duke JL, Liu M, Yaari G, Khalil AM, Tomayko MM, Shlomchik MJ, Schatz DG, Kleinstein SH.

J Immunol. 2013 Apr 15;190(8):3878-88. doi: 10.4049/jimmunol.1202547. Epub 2013 Mar 20.

10.

Cutting edge: Hierarchy of maturity of murine memory B cell subsets.

Tomayko MM, Steinel NC, Anderson SM, Shlomchik MJ.

J Immunol. 2010 Dec 15;185(12):7146-50. doi: 10.4049/jimmunol.1002163. Epub 2010 Nov 15.

11.

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.

Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ.

Nat Immunol. 2010 Jun;11(6):535-42. doi: 10.1038/ni.1877. Epub 2010 May 9.

12.

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Scholz JL, Crowley JE, Tomayko MM, Steinel N, O'Neill PJ, Quinn WJ 3rd, Goenka R, Miller JP, Cho YH, Long V, Ward C, Migone TS, Shlomchik MJ, Cancro MP.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15517-22. doi: 10.1073/pnas.0807841105. Epub 2008 Oct 1.

13.

Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Tomayko MM, Anderson SM, Brayton CE, Sadanand S, Steinel NC, Behrens TW, Shlomchik MJ.

J Immunol. 2008 Jul 1;181(1):27-38.

14.

New markers for murine memory B cells that define mutated and unmutated subsets.

Anderson SM, Tomayko MM, Ahuja A, Haberman AM, Shlomchik MJ.

J Exp Med. 2007 Sep 3;204(9):2103-14. Epub 2007 Aug 13.

15.

Intrinsic properties of human and murine memory B cells.

Anderson SM, Tomayko MM, Shlomchik MJ.

Immunol Rev. 2006 Jun;211:280-94. Review.

PMID:
16824135
16.

Characterization of mouse tGolgin-1 (golgin-245/trans-golgi p230/256 kD golgin) and its upregulation during oligodendrocyte development.

Cowan DA, Gay D, Bieler BM, Zhao H, Yoshino A, Davis JG, Tomayko MM, Murali R, Greene MI, Marks MS.

DNA Cell Biol. 2002 Jul;21(7):505-17.

PMID:
12162805
17.

Expression of the Bcl-2 family member A1 is developmentally regulated in T cells.

Tomayko MM, Punt JA, Bolcavage JM, Levy SL, Allman DM, Cancro MP.

Int Immunol. 1999 Nov;11(11):1753-61.

PMID:
10545479
18.

Long-lived B cells are distinguished by elevated expression of A1.

Tomayko MM, Cancro MP.

J Immunol. 1998 Jan 1;160(1):107-11.

19.

Human neuroblastoma cell lines regain catecholamine fluorescence when xenografted into athymic (nude) mice.

Tomayko MM, Triche TJ, Reynolds CP.

Int J Dev Neurosci. 1996 Oct;14(6):771-7.

PMID:
8960984
20.

Human neuroblastoma cell lines that express N-myc without gene amplification.

Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP.

Cancer. 1993 Dec 1;72(11):3346-54.

PMID:
8242562
21.

Determination of subcutaneous tumor size in athymic (nude) mice.

Tomayko MM, Reynolds CP.

Cancer Chemother Pharmacol. 1989;24(3):148-54.

PMID:
2544306
22.

Induction of catecholamine fluorescence in human neuroblastoma cell lines transplanted into nude mice.

Tomayko MM, Triche TJ, Newburgh RW, Reynolds CP.

Prog Clin Biol Res. 1988;271:307-16. No abstract available.

PMID:
3406004
23.

Biological classification of cell lines derived from human extra-cranial neural tumors.

Reynolds CP, Tomayko MM, Donner L, Helson L, Seeger RC, Triche TJ, Brodeur GM.

Prog Clin Biol Res. 1988;271:291-306. No abstract available.

PMID:
3406003

Supplemental Content

Loading ...
Support Center